Clinical Trials Logo

Filter by:
  • Withdrawn  
  • Page [1] ·  Next »
NCT ID: NCT03284658 Withdrawn - Metabolic Disorders Clinical Trials

Biomarker for the Early Diagnosis and Monitoring in Tyrosinemia Type 1 (BioTyrosin)

BioTyrosin
Start date: August 20, 2018
Phase:
Study type: Observational

Development of a new MS-based biomarker for the early and sensitive diagnosis of Tyrosinemia type 1 from blood (plasma)

NCT ID: NCT03264040 Withdrawn - Clinical trials for Alpha-Mannosidase Deficiency

Biomarker for Mannosidosis Disease (BioMannosidosis)

BioMannosido
Start date: August 20, 2018
Phase:
Study type: Observational

Development of a new MS-based biomarker for the early and sensitive diagnosis of Mannosidosis disease from blood (plasma)

NCT ID: NCT03198897 Withdrawn - Clinical trials for Lipoprotein Lipase Deficiency

Biomarker for Homozygous Familial Hypercholesterolemia (BioHoFH)

BioHoFH
Start date: August 20, 2018
Phase:
Study type: Observational

Development of a new MS-based biomarker for the early and sensitive diagnosis of Homozygous familial Hypercholesterolemia from blood

NCT ID: NCT03196115 Withdrawn - Clinical trials for Skin and Connective Tissue Diseases

Biomarker for Hyaline Fibromatosis Syndrome (BioHFS)

BioHFS
Start date: August 20, 2018
Phase:
Study type: Observational

Development of a new MS-based biomarker for the early and sensitive diagnosis of Hyaline fibromatosis syndrome from the blood

NCT ID: NCT02934854 Withdrawn - Clinical trials for Intellectual Disability

Biomarker for Creatine Deficiency Syndromes (BioCDS)

BioCDS
Start date: August 20, 2018
Phase:
Study type: Observational

Development of a new mass spectrometry-based biomarker for the ear-ly and sensitive diagnosis of the Creatine Deficiency Syndromes from dry-blood-spot sample

NCT ID: NCT02893280 Withdrawn - Clinical trials for Acute Coronary Syndrome

Acute Coronary Syndrome Sri Lanka Audit Project

ACSSLAP
Start date: April 2015
Phase: N/A
Study type: Observational

ACSSLAP is the first island wide audit project in Sri Lanka on ACS.

NCT ID: NCT02837523 Withdrawn - Hypophosphatemia Clinical Trials

Biomarker for Cystinosis Disease: BioCystinosis (BioCystinosis)

BioCystinosis
Start date: August 20, 2018
Phase:
Study type: Observational

Development of a new mass spectrometry-based biomarker for the early and sensitive diagnosis of Cystinosis disease from the blood

NCT ID: NCT02778295 Withdrawn - Clinical trials for Chronic Kidney Disease

Biomarker for Patients With Fabry Disease (BioFabry)

BioFabry
Start date: August 20, 2018
Phase:
Study type: Observational

Development of a new mass spectrography-based biomarker for the early and sensitive diagnosis of Fabry disease from the blood

NCT ID: NCT02712138 Withdrawn - Hyperbilirubinemia Clinical Trials

Biomarker for Gilbert Disease (BioGilbert)

BioGilbert
Start date: August 20, 2018
Phase:
Study type: Observational

Development of a new MS-based biomarker for the early and sensitive diagnosis of Gilbert disease from blood

NCT ID: NCT02603042 Withdrawn - Clinical trials for Defective Mineralization

Biomarker for Hypophosphatasia Disease (BioHypophos)

BioHypophos
Start date: August 20, 2018
Phase:
Study type: Observational

Development of a new MS-based biomarker for the early and sensitive diagnosis of Hypophosphatasia disease from plasma